The correlation between renal TRPM3 expression and baseline BP levels, alongside the protection against AngII-induced hypertension in Trpm3-KO mice, strongly suggests that TRPM3 represents a promising therapeutic target for hypertension management through its involvement in the final common pathway of renal Na+ excretion that regulates BP homeostasis. Here, TRPM3 is linked to hypertensive disorder.